Study guide
Transplant, Complement, Immunoglobulins, and Result Interpretation
ASCP MLT Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 ASCP MLT Exam Overview and Laboratory Operations
Current Exam Facts and CAT Scoring Eligibility Routes and MLT Study Strategy Laboratory Safety, Quality, and Compliance Lab Math, Instrumentation Troubleshooting, and Result Verification
2 Chemistry, Urinalysis, and Body Fluid Interpretation
Chemistry Calculations, Acid-Base, and Electrolytes Renal, Liver, Endocrine, Enzyme, TDM, and Toxicology Patterns Chemistry QC, Interferences, Specimen Handling, and Result Correlation Urinalysis Microscopy and Body Fluid Decision Patterns
3 Hematology and Hemostasis
CBC, RBC Indices, Reticulocytes, and Anemia Patterns Leukocyte Morphology, Differentials, and Disease Clues Platelet Findings, Coagulation Pathways, PT/aPTT, and Hemostasis Testing Hematology Quality Flags, Specimen Issues, and Smear Review Decisions
4 Blood Banking and Transfusion Practice
ABO/Rh Typing: Forward, Reverse, and Discrepancies Antibody Screen, Identification, DAT, Elution, and Enhancement Methods Compatibility Testing, Crossmatch, Components, and Storage Transfusion Reactions, HDFN, Donor/Product Decisions, and Safety Workflow
5 Microbiology Workups and Susceptibility Reasoning
Specimen Quality, Safety, and Culture Setup Gram Stain, Media, and Biochemical Identification Mycology, Mycobacteriology, Virology, and Parasitology Essentials Antimicrobial Susceptibility, QC, and Postanalytic Reporting
6 Immunology, Integrated Cases, and Final Review
Immunology Principles, Autoimmune Testing, Infectious Serology, and Molecular/Serologic Methods Transplant, Complement, Immunoglobulins, and Result Interpretation Integrated Case Reasoning Across Departments Final Seven-Day Review, CAT Pacing, and Remediation
Transplant, Complement, Immunoglobulins, and Result Interpretation
Key Takeaways Explain This Topic AI
Transplantation in the MLT immunology outline centers on HLA typing, graft-versus-host disease, and basic compatibility concepts.
Complement testing is most useful when interpreted as consumption, deficiency screening, or inflammation support rather than as a stand-alone diagnosis.
IgM usually signals early primary response and strong agglutination; IgG dominates secondary response and crosses the placenta.
Monoclonal immunoglobulin patterns suggest clonal plasma-cell or lymphoplasmacytic processes, while broad polyclonal increases suggest reactive immune stimulation.
Result interpretation should separate screening, identification, confirmation, monitoring, and critical communication duties.
Last updated: May 2026
Transplant Immunology At MLT Depth
The MLT guideline includes transplantation within Immunology and also places transplant-related immune concepts in blood banking and chemistry contexts. You do not need specialist-level histocompatibility detail for a general MLT review, but you do need the core vocabulary and the interpretation mindset.
Human leukocyte antigen (HLA) molecules present antigen and help the immune system distinguish self from nonself. In solid organ transplantation, HLA matching, antibody screening, crossmatch results, and donor-specific antibodies influence rejection risk. In hematopoietic progenitor cell transplantation, HLA compatibility is central, and immune cells from the graft can attack host tissues.
- Term What It Means Exam-Relevant Point
- HLA typing Determining HLA antigens/alleles Supports donor-recipient compatibility decisions
Donor-specific antibody Recipient antibody against donor HLA Raises concern for antibody-mediated rejection risk
Crossmatch Tests recipient serum/plasma against donor cells or antigens Positive results may indicate incompatible antibodies
Graft-versus-host disease Donor immune cells attack recipient tissues Classically tied to hematopoietic progenitor cell transplant
Immunosuppressant monitoring Drug levels such as tacrolimus in chemistry Links transplant care to therapeutic drug monitoring
Tumor immunology may appear as a broad idea: immune recognition, tumor markers, and monoclonal processes can intersect with hematology and chemistry. For MLT review, stay practical: know when a result suggests clonal immunoglobulin production and when additional characterization is needed.
Complement: Classical, Alternative, And Interpretation
Complement proteins amplify immune reactions. The classical pathway is usually triggered by antigen-antibody complexes, especially IgM or IgG. The alternative pathway can be activated directly on microbial surfaces. Both pathways converge on C3 activation and can progress toward membrane attack complex formation.
- Pattern Likely Meaning MLT Interpretation Cue
- Low C3 and low C4 Classical pathway consumption Consider immune-complex disease when clinical context fits
Low C3 with normal C4 Alternative pathway activation or consumption Correlate with infection, renal disease, or pathway-specific workup
Normal C3/C4 with symptoms Complement does not exclude disease Avoid overinterpreting normal screening markers
Low CH50 Classical terminal pathway abnormality or consumption AH50 helps separate alternative pathway issues if ordered
Decreased complement during lupus flare Immune-complex consumption Interpret with anti-dsDNA, urinalysis, renal markers, and symptoms
Complement results are not diagnosis labels. Low complement can reflect consumption, deficiency, specimen handling problems, or treatment effects. If the prompt includes nephritis, rash, anti-dsDNA, and low C3/C4, the best answer may be immune-complex activity. If the prompt includes recurrent Neisseria infections and abnormal total complement activity, inherited terminal pathway deficiency becomes more plausible.
Immunoglobulin Classes
Immunoglobulin class helps explain timing, location, and assay behavior.
Class High-Yield Features Common Testing Link
IgG Major secondary response antibody; crosses placenta; opsonizes and fixes complement by some subclasses Autoimmune antibodies, past exposure, hemolytic disease of fetus/newborn
IgM Early primary response; pentamer; strong agglutinator; efficient complement activator Acute infection marker, ABO antibodies, cold-reactive patterns
IgA Mucosal and secretory immunity; serum and secretory forms Mucosal infections and selected immunodeficiency workups
IgE Allergy and parasitic responses; binds mast cells and basophils Allergy testing and hypersensitivity context
IgD B-cell receptor role Low-yield as a routine diagnostic marker
For interpretation questions, class often tells timing. IgM anti-HBc supports recent hepatitis B infection. IgG rubella antibody generally supports immunity. IgG maternal antibodies can cross the placenta, which matters in hemolytic disease of the fetus and newborn and in neonatal serology interpretation.
Monoclonal Versus Polyclonal Patterns
Serum protein electrophoresis and immunofixation are common ways to evaluate immunoglobulin patterns. A narrow M-spike suggests monoclonal immunoglobulin production, such as monoclonal gammopathy of undetermined significance, plasma cell myeloma, or Waldenstrom macroglobulinemia. A broad gamma-region increase suggests polyclonal stimulation, which can occur with chronic infection, autoimmune disease, or liver disease.
Pattern What To Think Next Interpretation Step
Narrow spike in gamma or beta region Monoclonal protein Characterize heavy and light chain by immunofixation or equivalent method
Broad gamma elevation Polyclonal response Correlate with inflammation, infection, autoimmune disease, or liver disease
Hypogammaglobulinemia Decreased immunoglobulin production or loss Correlate with infection history, protein loss, and medication history
Urine light chains Possible plasma-cell disorder renal involvement Correlate with serum studies and renal markers
The MLT exam may not ask for specialist staging. It is more likely to test recognition: an M-spike is not a viral antibody screen, and a monoclonal pattern should not be dismissed as normal inflammation.
Result Interpretation Discipline
Use a bench checklist before choosing an answer:
Does the result match the ordered test and specimen type?
Is the result a screen, confirmation, identification, or monitoring value?
Are controls, calibration, and reagent performance acceptable?
Does the pattern fit the clinical timing?
Is reflex testing, repeat testing, dilution, or supervisor/pathologist review needed?
Is the result critical, reportable, or tied to immediate patient safety?
This same discipline applies across immunology, blood bank, chemistry, and microbiology. A result is not just a value; it is a value inside an algorithm.